SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-098035
Filing Date
2022-09-07
Accepted
2022-09-07 07:00:35
Documents
16
Period of Report
2022-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2225135d1_8k.htm   iXBRL 8-K 29322
2 EXHIBIT 99.1 tm2225135d1_ex99-1.htm EX-99.1 11049
3 EXHIBIT 99.2 tm2225135d1_ex99-2.htm EX-99.2 27818
7 GRAPHIC tm2225135d1_ex99-2img001.jpg GRAPHIC 10420
8 GRAPHIC tm2225135d1_ex99-1img001.jpg GRAPHIC 12380
  Complete submission text file 0001104659-22-098035.txt   287641

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lptx-20220901.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20220901_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20220901_pre.xml EX-101.PRE 22591
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2225135d1_8k_htm.xml XML 3708
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 221229893
SIC: 2834 Pharmaceutical Preparations